Blueprint Medicines Submits New Drug Application to the FDA to Treat Thyroid Cancer
source: pixabay.com

Blueprint Medicines Submits New Drug Application to the FDA to Treat Thyroid Cancer

  A recent article in BioSpace reported that Blueprint Medicines Corp. has submitted a New Drug Application (NDA) to the FDA for the investigational drug pralsetinib with an action date…

Continue Reading Blueprint Medicines Submits New Drug Application to the FDA to Treat Thyroid Cancer
Retevmo Approved for Treatment of Genetically-Mutated Lung and Thyroid Cancers
source: pixabay.com

Retevmo Approved for Treatment of Genetically-Mutated Lung and Thyroid Cancers

A recent BioSpace press release shares some exciting news for patients with non-small cell lung cancer, medullary thyroid cancer, and other thyroid cancers caused by RET gene mutations. Retevmo (selpercatinib) is the…

Continue Reading Retevmo Approved for Treatment of Genetically-Mutated Lung and Thyroid Cancers
Survivors of Thyroid Cancer Remain Concerned About Quality of Life and Treatment Effects, Study Says
Free-Photos / Pixabay

Survivors of Thyroid Cancer Remain Concerned About Quality of Life and Treatment Effects, Study Says

According to a story from Medscape, a recent study is highlighting the fact that many thyroid cancer survivors are still worried about cancer-related problems years after the conclusion of treatment.…

Continue Reading Survivors of Thyroid Cancer Remain Concerned About Quality of Life and Treatment Effects, Study Says
Biotech Companies Team Up to Launch MapKure, a New Joint Venture to Develop Small Molecule Anticancer Drug
rawpixel / Pixabay

Biotech Companies Team Up to Launch MapKure, a New Joint Venture to Develop Small Molecule Anticancer Drug

According to a press release from BeiGene, the Company and SpringWorks Therapeutics have launched MapKure, LLC — a new, jointly-operated venture owned by both partners. MapKure was founded to develop…

Continue Reading Biotech Companies Team Up to Launch MapKure, a New Joint Venture to Develop Small Molecule Anticancer Drug

For Childhood Survivors of Hodgkin Lymphoma, the Battle may not be Over

A recent article published in online CANCER NETWORK reports findings that indicate children who have survived Hodgkin lymphoma (HL) may develop solid tumors in later years. These findings will have…

Continue Reading For Childhood Survivors of Hodgkin Lymphoma, the Battle may not be Over
Girl Who Survived Thyroid Cancer at 17 Starts Organization to Support Teenage Patients
natureaddict / Pixabay

Girl Who Survived Thyroid Cancer at 17 Starts Organization to Support Teenage Patients

According to a story from nbcwashington.com, Nikki Ferraro was diagnosed with a rare type of thyroid cancer when she was just seventeen years old. While she was able to survive…

Continue Reading Girl Who Survived Thyroid Cancer at 17 Starts Organization to Support Teenage Patients
Second Ever Cancer Treatment Based on Biomarkers Approved by FDA
Source: Pixabay.com

Second Ever Cancer Treatment Based on Biomarkers Approved by FDA

On November 26, 2018, a new drug was given accelerated approval by the FDA. Not only that, but it was granted orphan drug designation and breakthrough therapy designation. The drug…

Continue Reading Second Ever Cancer Treatment Based on Biomarkers Approved by FDA
Interim Data Has Been Released From a Study of a Drug For RET-Altered Thyroid Cancer
DarkoStojanovic / Pixabay

Interim Data Has Been Released From a Study of a Drug For RET-Altered Thyroid Cancer

Loxo Oncology has shared interim clinical data from an ongoing study of the drug LOXO-292. The study, a Phase 1/2 clinical trial, involves patients with RET-mutant medullary thyroid cancer, as…

Continue Reading Interim Data Has Been Released From a Study of a Drug For RET-Altered Thyroid Cancer
Breakthrough Therapy Awarded to a Drug For RET-Altered Thyroid and Non-Small Cell Lung Cancers
DarkoStojanovic / Pixabay

Breakthrough Therapy Awarded to a Drug For RET-Altered Thyroid and Non-Small Cell Lung Cancers

The United States FDA has awarded Breakthrough Therapy Designation to a drug called LOXO-292 for the treatment of RET-altered non-small cell lung cancer and thyroid cancer, in patients who meet…

Continue Reading Breakthrough Therapy Awarded to a Drug For RET-Altered Thyroid and Non-Small Cell Lung Cancers
Could Flying Increase Risk of Thyroid Cancer? A New Study Says “Yes” for Flight Crew
Source: Pixabay

Could Flying Increase Risk of Thyroid Cancer? A New Study Says “Yes” for Flight Crew

According to a report by The Herald Scotland Online, a landmark study recently reveled flight crew to be exposed to greater than average risk of thyroid cancer. Surprisingly, the results…

Continue Reading Could Flying Increase Risk of Thyroid Cancer? A New Study Says “Yes” for Flight Crew
Could Flying Increase Risk of Thyroid Cancer? A New Study Says “Yes” for Flight Crew
Source: Pixabay

Could Flying Increase Risk of Thyroid Cancer? A New Study Says “Yes” for Flight Crew

According to a report by The Herald Scotland Online, a landmark study recently revealed that flight crews are exposed to greater risk than the average citizen. Surprisingly, the results have…

Continue Reading Could Flying Increase Risk of Thyroid Cancer? A New Study Says “Yes” for Flight Crew

Updated Results From Cancer Drug Trial Show Greater Improvements Than Previously Reported

According to a story from Reuters, the cancer drug developer Loxo Oncology recently released the latest results from the trial testing its investigational therapy LOXO-292. Preliminary results released about a…

Continue Reading Updated Results From Cancer Drug Trial Show Greater Improvements Than Previously Reported
Immunotherapies Could be the Next Major Treatment Innovation for Thyroid Cancer
source: pixabay.com

Immunotherapies Could be the Next Major Treatment Innovation for Thyroid Cancer

According to a story from news-medical.net, a team of researchers from the University of Colorado recently completed a study that assessed the genetics of thyroid cancer patients, drawing from a…

Continue Reading Immunotherapies Could be the Next Major Treatment Innovation for Thyroid Cancer
Close Menu